Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin-associated acute kidney injury in neonatal patent ductus arteriosus: 15-year experience
TCTR20190607002Completed
- Sponsor
- Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Prince of Songkla University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indomethacin in patent ductus arteriosus (PDA), sponsored by Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Prince of Songkla University. Primary endpoints: Incidence of acute kidney injury, Risk of acute kidney injury and 1 more. Started Jun 2019; status: completed.
02
Drugs
indomethacin
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on TCTR20190607002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190607002.